FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2336708411> ?p ?o ?g. }

• W2336708411 abstract "Overactivated microglia is involved in various kinds of neurodegenerative diseases. Suppression of microglial overactivation has emerged as a novel strategy for treatment of neuroinflammation-based neurodegeneration. In the current study, anti-inflammatory effects of oxytocin (OT), which is a highly conserved nonapeptide with hormone and neurotransmitter properties, were investigated in vitro and in vivo. BV-2 cells and primary microglia were pre-treated with OT (0.1, 1, and 10 μM) for 2 h followed by LPS treatment (500 ng/ml); microglial activation and pro-inflammatory mediators were measured by Western blot, RT-PCR, and immunofluorescence. The MAPK and NF-κB pathway proteins were assessed by Western blot. The intracellular calcium concentration ([Ca2+]i) was determined using Fluo2-/AM assay. Intranasal application of OT was pre-treated in BALB/C mice (adult male) followed by injected intraperitoneally with LPS (5 mg/kg). The effect of OT on LPS-induced microglial activation and pro-inflammatory mediators was measured by Western blot, RT-PCR, and immunofluorescence in vivo. Using the BV-2 microglial cell line and primary microglia, we found that OT pre-treatment significantly inhibited LPS-induced microglial activation and reduced subsequent release of pro-inflammatory factors. In addition, OT inhibited phosphorylation of ERK and p38 but not JNK MAPK in LPS-induced microglia. OT remarkably reduced the elevation of [Ca2+]i in LPS-stimulated BV-2 cells. Furthermore, a systemic LPS-treated acute inflammation murine brain model was used to study the suppressive effects of OT against neuroinflammation in vivo. We found that pre-treatment with OT showed marked attenuation of microglial activation and pro-inflammatory factor levels. Taken together, the present study demonstrated that OT possesses anti-neuroinflammatory activity and might serve as a potential therapeutic agent for treating neuroinflammatory diseases." @default.
• W2336708411 created "2016-06-24" @default.
• W2336708411 creator A5000315155 @default.
• W2336708411 creator A5003774228 @default.
• W2336708411 creator A5004231851 @default.
• W2336708411 creator A5004957511 @default.
• W2336708411 creator A5014295844 @default.
• W2336708411 creator A5017252015 @default.
• W2336708411 creator A5026053703 @default.
• W2336708411 creator A5065058975 @default.
• W2336708411 creator A5067223991 @default.
• W2336708411 creator A5070041760 @default.
• W2336708411 date "2016-04-13" @default.
• W2336708411 modified "2023-10-18" @default.
• W2336708411 title "Oxytocin inhibits lipopolysaccharide-induced inflammation in microglial cells and attenuates microglial activation in lipopolysaccharide-treated mice" @default.
• W2336708411 cites W1509956998 @default.
• W2336708411 cites W1536340959 @default.
• W2336708411 cites W1551533003 @default.
• W2336708411 cites W1813872274 @default.
• W2336708411 cites W1824256555 @default.
• W2336708411 cites W1965942744 @default.
• W2336708411 cites W1967644838 @default.
• W2336708411 cites W1983392780 @default.
• W2336708411 cites W1994068010 @default.
• W2336708411 cites W1999494818 @default.
• W2336708411 cites W2004349171 @default.
• W2336708411 cites W2011331018 @default.
• W2336708411 cites W2011361113 @default.
• W2336708411 cites W2018069416 @default.
• W2336708411 cites W2027065054 @default.
• W2336708411 cites W2031675610 @default.
• W2336708411 cites W2032113087 @default.
• W2336708411 cites W2036717742 @default.
• W2336708411 cites W2036735444 @default.
• W2336708411 cites W2046645259 @default.
• W2336708411 cites W2046682822 @default.
• W2336708411 cites W2051405502 @default.
• W2336708411 cites W2053176712 @default.
• W2336708411 cites W2055750901 @default.
• W2336708411 cites W2062835892 @default.
• W2336708411 cites W2067562221 @default.
• W2336708411 cites W2069923995 @default.
• W2336708411 cites W2070620348 @default.
• W2336708411 cites W2083325755 @default.
• W2336708411 cites W2086198325 @default.
• W2336708411 cites W2090868492 @default.
• W2336708411 cites W2091036510 @default.
• W2336708411 cites W2095069422 @default.
• W2336708411 cites W2111425451 @default.
• W2336708411 cites W2111433735 @default.
• W2336708411 cites W2112801385 @default.
• W2336708411 cites W2125030792 @default.
• W2336708411 cites W2125307799 @default.
• W2336708411 cites W2126742635 @default.
• W2336708411 cites W2131607023 @default.
• W2336708411 cites W2133205372 @default.
• W2336708411 cites W2153168701 @default.
• W2336708411 cites W2153508763 @default.
• W2336708411 cites W2159265751 @default.
• W2336708411 cites W2162458269 @default.
• W2336708411 cites W2165284425 @default.
• W2336708411 cites W2168161193 @default.
• W2336708411 cites W2169807760 @default.
• W2336708411 cites W2189881449 @default.
• W2336708411 cites W2470283318 @default.
• W2336708411 cites W300826572 @default.
• W2336708411 cites W4210981518 @default.
• W2336708411 doi "https://doi.org/10.1186/s12974-016-0541-7" @default.
• W2336708411 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4831099" @default.
• W2336708411 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27075756" @default.
• W2336708411 hasPublicationYear "2016" @default.
• W2336708411 type Work @default.
• W2336708411 sameAs 2336708411 @default.
• W2336708411 citedByCount "141" @default.
• W2336708411 countsByYear W23367084112016 @default.
• W2336708411 countsByYear W23367084112017 @default.
• W2336708411 countsByYear W23367084112018 @default.
• W2336708411 countsByYear W23367084112019 @default.
• W2336708411 countsByYear W23367084112020 @default.
• W2336708411 countsByYear W23367084112021 @default.
• W2336708411 countsByYear W23367084112022 @default.
• W2336708411 countsByYear W23367084112023 @default.
• W2336708411 crossrefType "journal-article" @default.
• W2336708411 hasAuthorship W2336708411A5000315155 @default.
• W2336708411 hasAuthorship W2336708411A5003774228 @default.
• W2336708411 hasAuthorship W2336708411A5004231851 @default.
• W2336708411 hasAuthorship W2336708411A5004957511 @default.
• W2336708411 hasAuthorship W2336708411A5014295844 @default.
• W2336708411 hasAuthorship W2336708411A5017252015 @default.
• W2336708411 hasAuthorship W2336708411A5026053703 @default.
• W2336708411 hasAuthorship W2336708411A5065058975 @default.
• W2336708411 hasAuthorship W2336708411A5067223991 @default.
• W2336708411 hasAuthorship W2336708411A5070041760 @default.
• W2336708411 hasBestOaLocation W23367084111 @default.
• W2336708411 hasConcept C104317684 @default.
• W2336708411 hasConcept C126322002 @default.
• W2336708411 hasConcept C134018914 @default.
• W2336708411 hasConcept C150903083 @default.
• W2336708411 hasConcept C185592680 @default.
• W2336708411 hasConcept C203014093 @default.

• next